Comprehensive profiling analysis of actively resorbing osteoclasts identifies critical signaling pathways regulated by bone substrate

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Purdue, P Edward ^a   Crotti, Tania N ^b,c   Shen, Zhenxin ^c   Swantek, Jennifer ^d   Li, Jun ^d   Hill, Jonathan ^d   Hanidu, Adedayo ^d   Dimock, Janice ^d   Nabozny, Gerald ^d   Goldring, Steven R ^a   McHugh, Kevin P ^e  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; OSTEOCLAST; OSTEOLYSIS; PHYSIOLOGY;

ANIMALS; BONE RESORPTION; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MICE; OSTEOCLASTS;

EID: 84942179751     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07595     Document Type: Article

References (49)

1. Goldring, S. R. & Gravallese, E. M. Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 12, 195-199 (2000).
2. Teitelbaum, S. L. Bone resorption by osteoclasts. Science 289, 1504-1508 (2000).
3. Nakashima, T., Hayashi, M. & Takayanagi, H. New insights into osteoclastogenic signaling mechanisms. Trends Endocrinol Metab 23, 582-590 (2012).
4. Boyle, W. J., Simonet, W. S. & Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337-342 (2003).
5. Teitelbaum, S. L. & Ross, F. P. Genetic regulation of osteoclast development and function. Nat Rev Genet 4, 638-649 (2003).
6. Ishida, N. et al. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 277, 41147-41156 (2002).
7. Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3, 889-901 (2002).
8. Crotti, T. N. et al. Bonematrix regulates osteoclast differentiation and annexin A8 gene expression. J Cell Physiol 226, 3413-3421 (2011).
9. McHugh, K. et al. Annexin VIII Is a Critical Bone Matrix-dependent Osteoclast Gene Transcriptionally Regulated by RANKL and NFATc1. Paper presented at: American Society for Bone and Mineral Research 29th Annual Meeting, Honolulu, Hawaii, USA. Published by AMER SOC BONE & MINERAL RES, 2025 M ST, NW, Ste 800, Washington, DC 20036-3309 USA, DOI: 10.1002/ jbmr.5650221409, 2007, September 19.
10. McHugh, K. P. et al. Role of cell-matrix interactions in osteoclast differentiation. Adv Exp Med Biol 602, 107-111 (2007).
11. McHugh, K. P. et al. The role of cell-substrate interaction in regulating osteoclast activation: potential implications in targeting bone loss in rheumatoid arthritis. Ann Rheum Dis 69 Suppl 1, i83-85 (2010).
12. McHugh, K. P. et al. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105, 433-440 (2000).
13. Ross, F. P. & Teitelbaum, S. L. alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology. Immunol Rev 208, 88-105 (2005).
14. Zhao, H. et al. Critical role of beta3 integrin in experimental postmenopausal osteoporosis. J Bone Miner Res 20, 2116-2123 (2005).
15. Bakewell, S. J. et al. Platelet and osteoclast beta3 integrins are critical for bone metastasis. Proc Natl Acad Sci U S A 100, 14205-14210 (2003).
16. Saltel, F., Destaing, O., Bard, F., Eichert, D. & Jurdic, P. Apatite-mediated actin dynamics in resorbing osteoclasts. Mol Biol Cell 15, 5231-5241 (2004).
17. McHugh, K. P., Kitazawa, S., Teitelbaum, S. L. & Ross, F. P. Cloning and characterization of the murine beta(3) integrin gene promoter: identification of an interleukin-4 responsive element and regulation by STAT-6. J Cell Biochem 81, 320-332 (2001).
18. Izawa, T. et al. c-Src links a RANK/alphavbeta3 integrin complex to the osteoclast cytoskeleton. Mol Cell Biol 32, 2943-2953 (2012).
19. Morgan, E. A. et al. Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit. FASEB J 24, 1117-1127 (2010).
20. Nakamura, I., Duong le, T., Rodan, S. B. & Rodan, G. A. Involvement of alpha(v)beta3 integrins in osteoclast function. J Bone Miner Metab 25, 337-344 (2007).
21. Nakamura, I., Lipfert, L., Rodan, G. A. & Le, T. D. Convergence of alpha(v)beta(3) integrin- and macrophage colony stimulating factor-mediated signals on phospholipase Cgamma in prefusion osteoclasts. J Cell Biol 152, 361-373 (2001).
22. Zhao, H., Ross, F. P. & Teitelbaum, S. L. Unoccupied alpha(v)beta3 integrin regulates osteoclast apoptosis by transmitting a positive death signal. Mol Endocrinol 19, 771-780 (2005).
23. Ishii, M. et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458, 524-528 (2009).
24. Ishii, M., Kikuta, J., Shimazu, Y., Meier-Schellersheim, M. & Germain, R. N. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. J Exp Med 207, 2793-2798 (2010).
25. Ishii, T., Shimazu, Y., Nishiyama, I., Kikuta, J. & Ishii, M. The role of sphingosine 1-phosphate in migration of osteoclast precursors; an application of intravital two-photon microscopy. Mol Cells 31, 399-403 (2011).
26. Kikuta, J. et al. Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D. Proc Natl Acad Sci U S A 110, 7009-7013 (2013).
27. Pederson, L., Ruan, M., Westendorf, J. J., Khosla, S. & Oursler, M. J. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A 105, 20764-20769 (2008).
28. Ryu, J. et al. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J 25, 5840-5851 (2006).
29. Nishi, T., Kobayashi, N., Hisano, Y., Kawahara, A. & Yamaguchi, A. Molecular and physiological functions of sphingosine 1-phosphate transporters. Biochim Biophys Acta 1841, 759-765 (2014).
30. Xiang, Y. et al. Discovery of novel sphingosine kinase-1 inhibitors. Part 2. Bioorg Med Chem Lett 20, 4550-4554 (2010).
31. Aliprantis, A. O. et al. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest 118, 3775-3789 (2008).
32. de la Rica, L. et al. PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation. Genome Biol 14, R99 (2013).
33. Mann, M., Barad, O., Agami, R., Geiger, B. & Hornstein, E. miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate. Proc Natl Acad Sci U S A 107, 15804-15809 (2010).
34. Miyauchi, Y. et al. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. J Exp Med 207, 751-762 (2010).
35. Mizoguchi, F., Murakami, Y., Saito, T., Miyasaka, N. & Kohsaka, H. miR-31 controls osteoclast formation and bone resorption by targeting RhoA. Arthritis Res Ther 15, R102 (2013).
36. Sharma, P., Patntirapong, S., Hann, S. & Hauschka, P. V. RANKL-RANK signaling regulates expression of xenotropic and polytropic virus receptor (XPR1) in osteoclasts. Biochem Biophys Res Commun 399, 129-132 (2010).
37. Wang, Y., Inger, M., Jiang, H., Tenenbaum, H. & Glogauer, M. CD109 plays a role in osteoclastogenesis. PLoS One 8, e61213 (2013).
38. Ogasawara, T. et al. Osteoclast differentiation by RANKL requires NF-kappaBmediated downregulation of cyclin-dependent kinase 6 (Cdk6). J Bone Miner Res 19, 1128-1136 (2004).
39. Rimondi, E., Zweyer, M., Ricci, E., Fadda, R. & Secchiero, P. Receptor activator of nuclear factor kappa B ligand (RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts. Anat Rec (Hoboken) 290, 838-845 (2007).
40. Sankar, U., Patel, K., Rosol, T. J. & Ostrowski, M. C. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1. J Bone Miner Res 19, 1339-1348 (2004).
41. Kim, H. J. et al. Suppression of osteoclastogenesis by N, N-dimethyl-D-erythrosphingosine: a sphingosine kinase inhibition-independent action. Mol Pharmacol 72, 418-428 (2007).
42. Baker, D. A., Barth, J., Chang, R., Obeid, L. M. & Gilkeson, G. S. Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis. J Immunol 185, 2570-2579 (2010).
43. Alvarez, S. E. et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465, 1084-1088 (2010).
44. Lam, J. T. S., Barker, J. E., Kanagawa, O., Ross, F. P. & Teitelbaum, S. L. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 106, 1481-1488 (2000).
45. Burstone, M. S. Histochemical demonstration of acid phosphatases with naphthol AS-phosphates. J Natl Cancer Inst 21, 523-539 (1958).
46. Subramanian, A. et al.Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102, 15545-15550 (2005).
47. Takeshita, S., Kaji, K. & Kudo, A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res 15, 1477-1488 (2000).
48. Rakshit, D. S. et al.Wear Debris Inhibition of Anti-Osteoclastogenic Signaling by Interleukin-6 and Interferon-{gamma}Mechanistic Insights and Implications for Periprosthetic Osteolysis. J Bone Joint Surg Am 88, 788-799 (2006).
49. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408 (2001).